Answers are grounded in this paper and cite their sources.
Background: To evaluate the possible toxic effect of a new angiotensin II receptor antagonist or blocker, olmesartan medoxomil, on the male reproductive system of rat. Methods: Twelve Sprague Dawley rats, randomly divided into two groups: treated group ( n =6) and control group ( n =6). Olmesartan medoxomil (5mg/kg/dose) was fed to the treated group once daily for 28 days. Sperm motility, count and morphology and pituitary gonadal hormonal levels were assessed. Results: Despite some fluctuations in sperm count, sperm motility, and concentration of testosterone, FSH and LH levels of treated group when compared to controls, the results were statistically insignificant. Conclusions: It is therefore concluded that olmesartan medoxomil did not adversely affect the male reproductive health of treated rats.
No takes yet. Share an insight, caveat, or question.
Jayachandra et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: